1.  Discuss the evidence for definitive local treatment of oligometastatic disease in NSCLC.

2.  Discuss the evidence for control of intra-cranial metastatic disease with immunotherapy or systemic therapy.

Session date: 
10/25/2018 - 8:00am to 9:00am CDT
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Sherin J. Rouhani, M.D.